4-[4-(4-Fluorophenyl)-2-[4-[(R)-methylsulfinyl]phenyl]-1H-imidazol-5-yl]pyridine

Star0

DB08521ExperimentalSmall molecule

4-[4-(4-Fluorophenyl)-2-[4-[(R)-methylsulfinyl]phenyl]-1H-imidazol-5-yl]pyridine: Overview.

Formula / weight: C₂₁H₁₆FN₃OS · 377.435 g/mol (avg)
Code names: BIRB-203580, (R)- · PB-203580, (R)- · (R)-SB-203580 · RWJ-64809, (R)-

Resolves to

Compound

UNIIWS78QR6DSVCAS652162-77-1PubChem40467016

Structure

InChIKeyCDMGBJANTYXAIV-HHHXNRCGSA-NSMILESC[S@@](=O)C1=CC=C(C=C1)C1=NC(=C(N1)C1=CC=NC=C1)C1=CC=C(F)C=C1

Targets

Q16539MAPK14P28482MAPK1

What you can answer from here — as of June 12, 2020

2Protein targetsEach mapped to UniProt, with action and pharmacological action

Listed above

2+ReferencesStructured and connected to the statements they support

Which drugs share a target with 4-[4-(4-Fluorophenyl)-2-[4-[(R)-methylsulfinyl]phenyl]-1H-imidazol-5-yl]pyridine, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account